Healthpeak Properties (NYSE:DOC) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Healthpeak Properties (NYSE:DOC) had its price target increased by research analysts at Royal Bank Of Canada from $20.00 to $21.00 in a report released on Thursday,Benzinga reports. The brokerage presently has an “outperform” rating on the real estate investment trust’s stock. Royal Bank Of Canada’s price objective would indicate a potential upside of 6.38% from the stock’s current price.

A number of other research firms have also recently commented on DOC. Scotiabank raised shares of Healthpeak Properties to a “hold” rating in a research note on Thursday, April 23rd. Evercore lowered Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price target on the stock. in a research note on Monday. Weiss Ratings raised Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Morgan Stanley lowered their price target on Healthpeak Properties from $21.00 to $18.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 28th. Finally, Citigroup lifted their price target on Healthpeak Properties from $17.50 to $20.00 and gave the stock a “neutral” rating in a research note on Tuesday. Five analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $18.92.

Healthpeak Properties Price Performance

Shares of DOC stock traded up $0.19 during trading hours on Thursday, hitting $19.74. 1,988,947 shares of the company’s stock were exchanged, compared to its average volume of 9,147,439. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. The firm has a market cap of $13.61 billion, a P/E ratio of 61.74, a P/E/G ratio of 2.73 and a beta of 1.00. The firm has a 50 day moving average of $17.19 and a two-hundred day moving average of $17.19. Healthpeak Properties has a fifty-two week low of $15.70 and a fifty-two week high of $19.91.

Healthpeak Properties (NYSE:DOC) last announced its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. The business had revenue of $752.95 million during the quarter, compared to the consensus estimate of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The business’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Sell-side analysts forecast that Healthpeak Properties will post 1.74 EPS for the current year.

Insider Buying and Selling

In related news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the transaction, the insider owned 7,636 shares in the company, valued at approximately $148,520.20. This trade represents a 59.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.23% of the company’s stock.

Hedge Funds Weigh In On Healthpeak Properties

A number of institutional investors have recently added to or reduced their stakes in the stock. Advocate Investing Services LLC purchased a new stake in shares of Healthpeak Properties in the fourth quarter valued at about $26,000. WPG Advisers LLC grew its holdings in shares of Healthpeak Properties by 270.2% in the fourth quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock valued at $26,000 after purchasing an additional 1,197 shares during the period. CYBER HORNET ETFs LLC purchased a new stake in shares of Healthpeak Properties in the second quarter valued at about $33,000. Clearstead Advisors LLC grew its holdings in shares of Healthpeak Properties by 166.3% in the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock valued at $31,000 after purchasing an additional 1,216 shares during the period. Finally, Elyxium Wealth LLC purchased a new stake in shares of Healthpeak Properties in the fourth quarter valued at about $31,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.